Hanbet Pharmaceuticals

Hanbet Pharmaceuticals is a South Korean pharmaceutical company focused on the development, manufacturing, and commercialization of a wide range of therapeutic products. The company specializes in metabolic diseases, cardiovascular health, and gastrointestinal treatments, offering both proprietary formulations and generic alternatives. Hanbet maintains a robust manufacturing infrastructure compliant with local regulatory standards to supply the domestic Korean market. Their portfolio includes treatments for chronic conditions such as type 2 diabetes and hypertension, as well as acute care medications. By leveraging strategic partnerships and a dedicated R&D focus, Hanbet aims to expand its presence in the East Asian healthcare sector.